Background: In the last few decades, numerous chemical compounds have been produced as a result of industrial development. At the same time, the number of atopic dermatitis (AD) patients has been increasing. It has been reported that tributyltin (TBT) compounds have effects not only on the reproductive system but also on the immune system. Objective: To investigate whether TBT has an effect on AD, we fed a diet containing TBT to DS-Nh mice, which spontaneously developed dermatitis under conventional conditions. Methods: DS-Nh mice fed TBT or a control diet were examined for skin changes, number of Staphylococcus aureus on the skin and serum IgE levels. To determine Th1/Th2 cytokine production by lymphocytes, lymphocytes of DS-Nh mice fed TBT and of controls were cultured with staphylococcal enterotoxin B and cytokine levels in the supernatants were measured by ELISA. We observed not only spontaneous dermatitis but also dermatitis induced by sensitization with 2,4,6-trinitrochlorobenzene (TNCB). Results and Conclusion: The AD-like lesions induced by TNCB sensitization were more severe in the mice fed TBT than in those fed the control diet. A greater increase in S. aureus on the skin was observed in the mice fed TBT than in the mice fed the control diet. A decrease in IFN-γ production and an increase in IL-5 and IL-13 production were observed in the mice fed the TBT diet and treated with TNCB. These findings suggest that the increase in S. aureus and the enhancement of Th2 response induced by TBT exacerbate the AD-like lesions in mice treated with TNCB.

Keywords:
Th1/Th2 balance, Atopic dermatitis, Staphylococcus aureus, Endocrine disruptor
1.
Pastore S, Mascia F, Giustizieri ML, Gianetti A, Girolomoni G: Pathogenetic mechanisms of atopic dermatitis. Arch Immunol Ther Exp (Warsz) 2000;48:497–504.
2.
Leung DYM: Atopic dermatitis: new insights and opportunities for therapeutic intervention. J Allergy Clin Immunol 2000;105:860–876.
3.
Romagnani S: The role of lymphocytes in allergic disease. J Allergy Clin Immunol 2000;105:399–408.
4.
Akdis CA, Akdis M, Trautmann A, Blaser K: Immune regulation in atopic dermatitis. Curr Opin Immunol 2000;12:641–646.
5.
Leung DYM: Atopic dermatitis: immunobiology and treatment with immune modulators. Clin Exp Immunol 1997;107:25–30.
6.
Jujo K, Renz H, Abe J, Gelfand EW, Leung DYM: Decreased interferon gamma and increased interleukin-4 in atopic dermatitis promotes IgE synthesis. J Allergy Clin Immunol 1992;90:323–331.
7.
Poulsen LK, Reimert CM, Bindslev-Jensen C, Hansen MB, Bendzen K: Biomolecular regulation of the IgE immune response. II. In vitro IgE synthesis and spontaneous production of cytokines. Int Arch Allergy Immunol 1995;106:55–61.
8.
Leung DYM: Atopic dermatitis: new insights and opportunities for therapeutic intervention. J Allergy Clin Immunol 2000;105:860–876.
9.
Sekizawa J, Suter G, Birnbaum L: Tributyltin and Triphenyltin Compounds. Geneva, World Health Organization, 2001.
10.
Bryan GW, Gibbs PE, Huggett RJ, Curtis LA, Bailey DS, Dauer DM: Effects of tributyltin pollution on the mud snail, Ilyanassa obsoleta, from the York River and Sarah Creek, Chesapeake Bay. Mar Pollut Bull 1989;20:458–462.
11.
Oberdörster E, McClellan-Green P: Mechanisms of imposex induction in the mud snail, Ilyanassa obsoleta: TBT as a neurotoxin and aromatase inhibitor. Mar Environ Res 2002;54:715–718.
12.
Ellis DV, Pattisina LA: Widespread neogastropod imposex: a biological indicator of global TBT contamination? Mar Pollut Bull 1990;21:248–253.
13.
Krajnc EI, Wester PW, Loeber JG, van Leeuwen FXR, Vos JG, Vaessen HAMG, van der Heijden CA: Toxicity of bis(tri-n-butyltin)oxide in the rat. I. Short-term effects on general parameters and on the endocrine and lymphoid systems. Toxicol Appl Pharmacol 1984;75:363–386.
14.
Snoeij NJ, Penninks AH, Seinen W: Biological activity of organotin compounds: an overview. Environ Res 1987;44:335–353.
15.
Ishaaya I, Engel JL, Casida JE: Dietary triorganotins affect lymphatic tissues and blood composition of mice. Pestic Biochem Physiol 1976;6:270–279.
16.
Haraguchi M, Hino M, Tanaka H, Maru M: Naturally occurring dermatitis associated with Staphylococcus aureus in DS-Nh mice. Exp Anim 1997;46:225–229.
17.
Hikita I, Yoshioka T, Mizoguchi T, Tsukahara I, Tsuru K, Nagai H, Hirasawa T, Tsuruta Y, Suzuki R, Ichihashi M, Horikawa T: Characterization of dermatitis arising spontaneously in DS-Nh mice maintained under conventional conditions: another possible model for atopic dermatitis. J Dermatol Sci 2002;30:142–153.
18.
Kitagaki H, Kimishima M, Teraki Y, Hayakawa J, Hayakawa K, Fujisawa S, Shiohara T: Distinct in vivo and in vitro cytokine profiles of draining lymph node cells in acute and chronic phases of contact hypersensitivity: importance of a type 2 cytokine-rich cutaneous milieu for the development of an early-type response in the chronic phase. J Immunol 1999;163:1265–1273.
19.
Matsukura S, Aihara M, Hirasawa T, Ikezawa Z: Effects of TNCB sensitization in DS-Nh mice serving as a model of atopic dermatitis, in comparison with NC/Nga mice. Int Arch Allergy Immunol 2005;136:173–180.
20.
Cookson W: The alliance of genes and environment in asthma and allergy. Nature 1999;402:B5–B11.
21.
Dobson S, Cabridenc R : Tributyltin Compounds. Environmental Health Criteria 116. Geneva, International Programme on Chemical Safety/World Health Organization, 1990.
22.
Kannan K, Senthilkumar K, Giesy JP: Occurrence of butyltin compounds in human blood. Environ Sci Technol 1999;33:1776–1779.
23.
Harino H, Fukushima M, Kawai S: Accumulation of butyltin and phenyltin compounds in various fish species. Arch Environ Contam Toxicol 2000;39:13–19.
24.
Vos JG, de Klerk A, Krajnc EI, Kruizinga W, van Ommen B, Rozing J: Toxicity of bis(tri-n-butyltin)oxide in the rat. II. Suppression of thymus-dependent immune responses and of parameters of nonspecific resistance after short-term exposure. Toxicol Appl Pharmacol 1984;75:387–408.
25.
Fong TAT, Mosmann TR: The role of IFN-gamma in delayed-type hypersensitivity mediated by Th1 clones. J Immunol 1989;143:2887–2893.
26.
Seinen W, Vos JG, van Krieken R, Penninks A, Brands R, Hooykaas H: Toxicity of organotin compounds. III. Suppression of thymus-dependent immunity in rats by di- n-butyltinchloride and di-n-octyltindichlo- ride. Toxicol Appl Pharmacol 1977;42:213–224.
27.
Karpuzoglu-Sahin E, Zhi-Jun Y, Lengi A, Sriranganathan N, Ansar AS: Effects of long-term estrogen treatment on IFN-gamma, IL-2 and IL-4 gene expression and protein synthesis in spleen and thymus of normal C57BL/6 mice. Cytokine 2001;14:208–217.
28.
Punnonen J, Aversa G, Cocks BG, McKenzie AN, Menon S, Zurawski G, de Waal Malefyt R, de Vries JE: Interleukin-13 induces interleukin-4-independent IgG4 and IgE synthesis and CD23 expression by human B cells. Proc Natl Acad Sci USA 1993;90:3730–3734.
29.
Akdis CA, Akdis M, Simon D, Dibbert B, Weber M, Gratzl S, Kreyden O, Disch R, Wüthrich B, Blaser K, Simon H-U: T cells and T cell-derived cytokines as pathogenic factors in the nonallergic form of atopic dermatitis. J Invest Dermatol 1999;113:628–635.
30.
Vos JG, De Klerk A, Krajnc EI, Van Loveren H, Rozing J: Immunotoxicity of bis(tri-n-butyltin)oxide in the rat: effects on thymus-dependent immunity and on nonspecific resistance following long-term exposure in young versus aged rats. Toxicol Appl Pharmacol 1990;105:144–155.
31.
Ong PY, Ohtake T, Brandt C, Strickland I, Boguniewicz M, Ganz T, Gallo RL, Leung DYM: Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med 2002;347:1151–1160.
32.
Herz U, Bunikowski R, Renz H: Role of T cells in atopic dermatitis: new aspects on the dynamics of cytokine production and the contribution of bacterial superantigens. Int Arch Allergy Immunol 1998;115:179–190.
33.
McFadden JP, Noble WC, Camp RDR: Superantigenic exotoxin-secreting potential of staphylococci isolated from atopic eczematous skin. Br J Dermatol 1993;128:631–632.
34.
Strickland I, Hauk PJ, Trumble AE, Picker LJ, Leung DYM: Evidence for superantigen involvement in skin homing of T cells in atopic dermatitis. J Invest Dermatol 1999;112:249–253.
35.
Purwar R, Werfel T, Wittmann M: IL-13-stimulated human keratinocytes preferentially attract CD4+CCR4+ T cells: possible role in atopic dermatitis. J Invest Dermatol 2006;126:1043–1051.
© 2006 S. Karger AG, Basel
2006
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.